Tracking what predicts response in new PMR or GCA
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study looks at people newly diagnosed with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) and uses their health and treatment information to learn what predicts how well treatment works. It may help your care in the future by improving which patients respond best and how.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of PMR or GCA based on standard criteria
- You agree to let the study store your information in the SCQM database
- You will be treated using the study’s standard treatment plan
- You have not taken tocilizumab, methotrexate, or other disease-modifying medicines before joining
- You have no past history of GCA or PMR before this new diagnosis
- You can understand the study and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood test for a protein called thrombomodulin can help rule out giant cell arteritis (a blood vessel inflammation) in people with polymyalgia rheumatica. It involves a blood draw and a one-time imaging scan to look at your blood vessels.
This trial tests if new imaging methods can help diagnose and treat polymyalgia rheumatica (PMR). It may be for you if you're over 50, have pain in your shoulders or hips, and haven't taken steroids for PMR in the last 2 months.
This study tracks patients with giant cell arteritis (GCA, a blood vessel inflammation affecting older adults) who are in remission and tapering their steroid medications. Researchers will monitor disease activity through blood tests and patient questionnaires to understand if their condition stays stable as they reduce treatment.
This study looks at blood markers related to DNA changes in people with polymyalgia rheumatica (PMR). It aims to better understand the condition and may help guide future treatments.
This study looks at immune cells called B-cells in people with giant cell arteritis (a condition causing inflammation in blood vessels) and other immune disorders, to see if targeting these cells could be a new treatment. It involves imaging and blood tests.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
Hear when a new Polymyalgia Rheumatica (PMR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.